A study of the effect of gender on interferon beta-1a (Avonex® 30 mcg) treatment in patients with multiple sclerosis

被引：0
|
作者：
Munschauer, FE
Herndon, R
Sandrock, AW
Tsao, E
Berkhoff, JE
Stubbendick, A
机构：
[1] Jacobs Neurol Inst, Buffalo, NY USA
[2] Univ Mississippi, Jackson, MS 39216 USA
[3] Biogen Idec, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [41] Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis
    Mohr, DC
    Likosky, W
    Dwyer, P
    Van der Wende, J
    Boudewyn, AC
    Goodkin, DE
    ARCHIVES OF NEUROLOGY, 1999, 56 (10) : 1263 - 1265
  • [42] Interferon-β-1a (Avonex) 30 mcg and 60 mcg are equally effective in patients with relapsing multiple sclerosis:: results from the Cyprus study site of the European IFNβ-1a Dose Comparison Study
    Kkolou, E
    Papacostas, S
    Kyriallis, K
    Toufexis, J
    Pantzaris, M
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S243 - S243
  • [43] Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis
    Mahe, Julien
    Meurette, Aurelie
    Moreau, Anne
    Vercel, Caroline
    Jolliet, Pascale
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 723 - 728
  • [44] Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a
    Pakdaman, H.
    Fallah, A.
    Sahraian, M. A.
    Pakdaman, R.
    Meysamie, A.
    NEUROPEDIATRICS, 2006, 37 (04) : 257 - 260
  • [45] Utilization of the multiple sclerosis functional composite as an outcome measure in the phase 3 trial of interferon beta-1a (Avonex®) in secondary progressive multiple sclerosis (IMPACT)
    Cohen, JA
    Cutter, GC
    Simonian, NA
    Goodman, AD
    Heidenreich, FR
    Simon, JH
    Whitaker, JN
    NEUROLOGY, 1999, 52 (06) : A548 - A549
  • [46] EFFECT OF INTERFERON BETA-1A SC ON LESION IRON CONTENT IN MULTIPLE SCLEROSIS
    Zivadinov, Robert
    Markovic-Plese, Silva
    Dwyer, Michael G.
    Hayward, Brooke
    Bergsland, Niels
    Heininen-Brown, Mari
    Carl, Ellen
    Kennedy, Cheryl
    Dangond, Fernando
    Weinstock-Guttman, Bianca
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1416 - 1417
  • [47] The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis
    Patten, SB
    Francis, G
    Metz, LM
    Lopez-Bresnahan, M
    Chang, P
    Curtin, F
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) : 175 - 181
  • [48] Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a
    Almeida, L.
    Neves, M.
    Cardoso, E.
    Melo, A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (01) : 125 - 127
  • [49] Risk of stroke in patients with multiple sclerosis treated with subcutaneous interferon beta-1a
    Sabido-Espin, M.
    Venkatesh, S.
    Aldridge, J.
    Gillett, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 1022 - 1022
  • [50] Visual evoked potentials in multiple sclerosis patients treated with interferon beta-1a
    Liscic, RM
    Brecelj, J
    CROATIAN MEDICAL JOURNAL, 2004, 45 (03) : 323 - 327
12345